BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 14752107)

  • 1. DNA-dependent protein kinase and checkpoint kinase 2 synergistically activate a latent population of p53 upon DNA damage.
    Jack MT; Woo RA; Motoyama N; Takai H; Lee PW
    J Biol Chem; 2004 Apr; 279(15):15269-73. PubMed ID: 14752107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ataxia telangiectasia mutated (ATM) and ATM and Rad3-related protein exhibit selective target specificities in response to different forms of DNA damage.
    Helt CE; Cliby WA; Keng PC; Bambara RA; O'Reilly MA
    J Biol Chem; 2005 Jan; 280(2):1186-92. PubMed ID: 15533933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ATR-Chk2 signaling in p53 activation and DNA damage response during cisplatin-induced apoptosis.
    Pabla N; Huang S; Mi QS; Daniel R; Dong Z
    J Biol Chem; 2008 Mar; 283(10):6572-83. PubMed ID: 18162465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA damage-induced activation of p53 by the checkpoint kinase Chk2.
    Hirao A; Kong YY; Matsuoka S; Wakeham A; Ruland J; Yoshida H; Liu D; Elledge SJ; Mak TW
    Science; 2000 Mar; 287(5459):1824-7. PubMed ID: 10710310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chk2 is a tumor suppressor that regulates apoptosis in both an ataxia telangiectasia mutated (ATM)-dependent and an ATM-independent manner.
    Hirao A; Cheung A; Duncan G; Girard PM; Elia AJ; Wakeham A; Okada H; Sarkissian T; Wong JA; Sakai T; De Stanchina E; Bristow RG; Suda T; Lowe SW; Jeggo PA; Elledge SJ; Mak TW
    Mol Cell Biol; 2002 Sep; 22(18):6521-32. PubMed ID: 12192050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of CHK2 by DNA-dependent protein kinase.
    Li J; Stern DF
    J Biol Chem; 2005 Mar; 280(12):12041-50. PubMed ID: 15668230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The plant isoflavenoid genistein activates p53 and Chk2 in an ATM-dependent manner.
    Ye R; Bodero A; Zhou BB; Khanna KK; Lavin MF; Lees-Miller SP
    J Biol Chem; 2001 Feb; 276(7):4828-33. PubMed ID: 11096068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Purification and characterization of ATM from human placenta. A manganese-dependent, wortmannin-sensitive serine/threonine protein kinase.
    Chan DW; Son SC; Block W; Ye R; Khanna KK; Wold MS; Douglas P; Goodarzi AA; Pelley J; Taya Y; Lavin MF; Lees-Miller SP
    J Biol Chem; 2000 Mar; 275(11):7803-10. PubMed ID: 10713094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arsenic trioxide augments Chk2/p53-mediated apoptosis by inhibiting oncogenic Wip1 phosphatase.
    Yoda A; Toyoshima K; Watanabe Y; Onishi N; Hazaka Y; Tsukuda Y; Tsukada J; Kondo T; Tanaka Y; Minami Y
    J Biol Chem; 2008 Jul; 283(27):18969-79. PubMed ID: 18482988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphorylation of p53 on Ser15 during cell cycle caused by Topo I and Topo II inhibitors in relation to ATM and Chk2 activation.
    Zhao H; Traganos F; Darzynkiewicz Z
    Cell Cycle; 2008 Oct; 7(19):3048-55. PubMed ID: 18802408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chk2 is dispensable for p53-mediated G1 arrest but is required for a latent p53-mediated apoptotic response.
    Jack MT; Woo RA; Hirao A; Cheung A; Mak TW; Lee PW
    Proc Natl Acad Sci U S A; 2002 Jul; 99(15):9825-9. PubMed ID: 12097646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Doxorubicin activates ATM-dependent phosphorylation of multiple downstream targets in part through the generation of reactive oxygen species.
    Kurz EU; Douglas P; Lees-Miller SP
    J Biol Chem; 2004 Dec; 279(51):53272-81. PubMed ID: 15489221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperoxia activates the ATR-Chk1 pathway and phosphorylates p53 at multiple sites.
    Das KC; Dashnamoorthy R
    Am J Physiol Lung Cell Mol Physiol; 2004 Jan; 286(1):L87-97. PubMed ID: 12959929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Death receptor-induced activation of the Chk2- and histone H2AX-associated DNA damage response pathways.
    Solier S; Sordet O; Kohn KW; Pommier Y
    Mol Cell Biol; 2009 Jan; 29(1):68-82. PubMed ID: 18955500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topoisomerase inhibitor coralyne photosensitizes DNA, leading to elicitation of Chk2-dependent S-phase checkpoint and p53-independent apoptosis in cancer cells.
    Patro BS; Maity B; Chattopadhyay S
    Antioxid Redox Signal; 2010 Apr; 12(8):945-60. PubMed ID: 19922265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The ability of p53 to activate downstream genes p21(WAF1/cip1) and MDM2, and cell cycle arrest following DNA damage is delayed and attenuated in scid cells deficient in the DNA-dependent protein kinase.
    Kachnic LA; Wu B; Wunsch H; Mekeel KL; DeFrank JS; Tang W; Powell SN
    J Biol Chem; 1999 May; 274(19):13111-7. PubMed ID: 10224064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. hSMG-1 and ATM sequentially and independently regulate the G1 checkpoint during oxidative stress.
    Gehen SC; Staversky RJ; Bambara RA; Keng PC; O'Reilly MA
    Oncogene; 2008 Jul; 27(29):4065-74. PubMed ID: 18332866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ATM-dependent CHK2 activation induced by anticancer agent, irofulven.
    Wang J; Wiltshire T; Wang Y; Mikell C; Burks J; Cunningham C; Van Laar ES; Waters SJ; Reed E; Wang W
    J Biol Chem; 2004 Sep; 279(38):39584-92. PubMed ID: 15269203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA protein kinase-dependent G2 checkpoint revealed following knockdown of ataxia-telangiectasia mutated in human mammary epithelial cells.
    Arlander SJ; Greene BT; Innes CL; Paules RS
    Cancer Res; 2008 Jan; 68(1):89-97. PubMed ID: 18172300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PML-dependent apoptosis after DNA damage is regulated by the checkpoint kinase hCds1/Chk2.
    Yang S; Kuo C; Bisi JE; Kim MK
    Nat Cell Biol; 2002 Nov; 4(11):865-70. PubMed ID: 12402044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.